
Neuroleptic malignant syndrome associated with concomitant use of levodopa and benserazide hydrochloride, olanzapine, and chlorpromazine
Wang Haifei
Neuroleptic malignant syndrome associated with concomitant use of levodopa and benserazide hydrochloride, olanzapine, and chlorpromazine
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |